Table 1 Median survival according to known prognostic factors, PLK1 and CDK1 expression

From: An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma

Age

<60 years vs ⩾60 years

18.2 vs 9.6 months

P=0.001

Histological subtype

Epithelioid vs non-epithelioid

18.7 vs 7.7 months

P<0.001

Gender

Male vs female

11.5 vs 21.9 months

P=0.007

PLK1 expression

<10% vs ⩾10%

15.5 vs 5.0 months

P=0.004

CDK1 expression

<20% vs ⩾20%

15.7 vs 11.5 months

P=0.388

Back to article page